161 related articles for article (PubMed ID: 32330737)
1. A drug-like imidazole-benzothiazole conjugate inhibits malignant melanoma by stabilizing the c-MYC G-quadruplex.
Wu TY; Huang Q; Huang ZS; Hu MH; Tan JH
Bioorg Chem; 2020 Jun; 99():103866. PubMed ID: 32330737
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
[TBL] [Abstract][Full Text] [Related]
3. Drug-like biimidazole derivatives dually target c-MYC/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia.
Hu MH; Yu BY; Wang X; Jin G
Bioorg Chem; 2020 Nov; 104():104264. PubMed ID: 32920366
[TBL] [Abstract][Full Text] [Related]
4. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription.
Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene
Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D
J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078
[TBL] [Abstract][Full Text] [Related]
6. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
Hu MH; Lin XT; Liu B; Tan JH
Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
[TBL] [Abstract][Full Text] [Related]
8. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
9. APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells.
Local A; Zhang H; Benbatoul KD; Folger P; Sheng X; Tsai CY; Howell SB; Rice WG
Mol Cancer Ther; 2018 Jun; 17(6):1177-1186. PubMed ID: 29626127
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel 11-Triazole Substituted Benzofuro[3,2-b]quinolone Derivatives as c-myc G-Quadruplex Specific Stabilizers via Click Chemistry.
Zeng DY; Kuang GT; Wang SK; Peng W; Lin SL; Zhang Q; Su XX; Hu MH; Wang H; Tan JH; Huang ZS; Gu LQ; Ou TM
J Med Chem; 2017 Jul; 60(13):5407-5423. PubMed ID: 28514170
[TBL] [Abstract][Full Text] [Related]
11. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
[TBL] [Abstract][Full Text] [Related]
12. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
[TBL] [Abstract][Full Text] [Related]
13. 5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions.
Wei ZZ; Qin QP; Meng T; Deng CX; Liang H; Chen ZF
Eur J Med Chem; 2018 Feb; 145():360-369. PubMed ID: 29335202
[TBL] [Abstract][Full Text] [Related]
14. Non-fused imidazole-biphenyl analogs repress triple-negative breast cancer growth by mainly stabilizing the c-MYC G-quadruplex via a multi-site binding mode.
Wang XD; Wang JX; Yu BY; Zhang SQ; Hu MH
Bioorg Med Chem; 2023 Jun; 88-89():117336. PubMed ID: 37209638
[TBL] [Abstract][Full Text] [Related]
15. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Hu MH; Lin JH
J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity and cellular repression of c-MYC by the G-quadruplex-stabilizing 11-piperazinylquindoline is not dependent on direct targeting of the G-quadruplex in the c-MYC promoter.
Boddupally PV; Hahn S; Beman C; De B; Brooks TA; Gokhale V; Hurley LH
J Med Chem; 2012 Jul; 55(13):6076-86. PubMed ID: 22691117
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex.
Shan C; Yan JW; Wang YQ; Che T; Huang ZL; Chen AC; Yao PF; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
J Med Chem; 2017 Feb; 60(4):1292-1308. PubMed ID: 28128954
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in Vitro Evaluation of Novel 5-Nitroindole Derivatives as c-Myc G-Quadruplex Binders with Anticancer Activity.
Nimbarte VD; Wirmer-Bartoschek J; Gande SL; Alshamleh I; Seibert M; Nasiri HR; Schnütgen F; Serve H; Schwalbe H
ChemMedChem; 2021 May; 16(10):1667-1679. PubMed ID: 33508167
[TBL] [Abstract][Full Text] [Related]
19. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex.
Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J
Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718
[TBL] [Abstract][Full Text] [Related]
20. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
